Home > Press > Applied Nanotech Holdings to Host Investor Day in Austin TX on November 16, 2011: Releases Third Quarter Shareholder Letter
Abstract:
Applied Nanotech Holdings, Inc. (OTCBB:APNT) is pleased to announce that it will host an investor day at 10:00 am CST on Wednesday, November 16, 2011 in Austin, Texas at the Embassy Suites Austin Arboretum, 9505 Stonelake Blvd., Austin, TX 78759.
The investor day will include presentations by Applied Nanotech management followed by an open house at the company's facilities. Management presentations will discuss the company's milestones achieved in its four key technology areas of Nanocomposites, Thermal Management, Nanoelectronics and Nanosensors and addressable markets, with a particular focus on providing deeper insights into those technologies that have reached, or are nearing, the commercialization stage. Management will also discuss the company's growth strategy and long-term outlook for the company.
"We encourage all shareholders to visit with us in person to gain a greater understanding of our technology, future prospects and our road to long-term growth," said Doug Baker, CEO of Applied Nanotech Holdings, Inc.
What: 2011 Investor Day
Where: Embassy Suites Austin Arboretum, 9505 Stonelake Boulevard, Austin, TX 78759
When: November 16, 2011 - 10am - 12pm CST
Applied Nanotech also recently issued their third quarter shareholder letter which can be found at the company's website at appliednanotech.net/investors/shareholder_comm_2011-Nov.php.
####
About Applied Nanotech Holdings, Inc.
Applied Nanotech Holdings, Inc. is a global nanotechnology leader, focused on solving problems at the molecular level, and commercializing the results of its research. Its team of PhD-level scientists and engineers work with companies and other organizations to solve technical impasses and create innovations that will create a competitive advantage. The business model is to sell products and license patents and technology to partners that will manufacture and distribute products using the technology. Applied Nanotech has over 300 patents or patents pending.
Safe Harbor Statement
This letter contains forward-looking statements that involve risks and uncertainties concerning our business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report on Form 10-K for the fiscal year ended December 31, 2010, and in reports subsequently filed by us with the Securities and Exchange Commission ("SEC"). All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval System (EDGAR) at www.sec.gov or from our website at www.appliednanotech.net. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances.
For more information, please click here
Contacts:
Doug Baker
Applied Nanotech Holdings, Inc.
248.391.0612
Copyright © GlobeNewswire, Inc.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||